Jmac Enterprises LLC Amgen Inc Transaction History

Jmac Enterprises LLC

$610 Million
Q3 2024

A detailed history of Jmac Enterprises LLC transactions in Amgen Inc stock. As of the latest transaction made, Jmac Enterprises LLC holds 96,671 shares of AMGN stock, worth $25.4 Million. This represents 5.11% of its overall portfolio holdings.

Number of Shares

96,671

Previous 96,550 0.13%

Holding current value

$25.4 Million

Previous $30.2 Million 3.25%

% of portfolio

5.11%

Previous 5.43%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$309.38 - $337.38 $37,434 - $40,822	121 Added 0.13%	96,671 $31.1 Million
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $90,386 - $109,842	344 Added 0.36%	96,550 $30.2 Million
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $83,618 - $100,938	311 Added 0.32%	96,206 $27.4 Million
Q4 2023 Jan 26, 2024	BUY	$255.7 - $288.46 $379,714 - $428,363	1,485 Added 1.57%	95,895 $27.6 Million
Q3 2023 Oct 19, 2023	BUY	$218.65 - $271.46 $133,813 - $166,133	612 Added 0.65%	94,410 $25.4 Million
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $48,210 - $57,008	225 Added 0.24%	93,798 $20.8 Million
Q1 2023 Apr 20, 2023	SELL	$225.79 - $275.2 $29,352 - $35,776	-130 Reduced 0.14%	93,573 $22.6 Million
Q4 2022 Jan 23, 2023	SELL	$229.03 - $291.01 $45,576 - $57,910	-199 Reduced 0.21%	93,703 $0
Q3 2022 Oct 20, 2022	BUY	$224.46 - $253.15 $98,313 - $110,879	438 Added 0.47%	93,902 $21.2 Million
Q2 2022 Jul 25, 2022	SELL	$230.71 - $256.74 $237,862 - $264,698	-1,031 Reduced 1.09%	93,464 $22.7 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $1.38 Million - $1.53 Million	-6,307 Reduced 6.26%	94,495 $22.9 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $20 Million - $22.9 Million	100,802 New	100,802 $24.3 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jmac Enterprises LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jmac Enterprises LLC with notifications on news.

Account

Jmac Enterprises LLC Amgen Inc Transaction History